Related references
Note: Only part of the references are listed.Iron metabolism and iron disorders revisited in the hepcidin era
Clara Camaschella et al.
HAEMATOLOGICA (2020)
Effects of Interleukin-1β Inhibition on Incident Anemia Exploratory Analyses From a Randomized Trial
Mounica Vallurupalli et al.
ANNALS OF INTERNAL MEDICINE (2020)
Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
Patrizio Scarozza et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Li Zuo-Lin et al.
KIDNEY DISEASES (2020)
First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis
Lutz Renders et al.
PLOS ONE (2019)
Anemia of Inflammation with An Emphasis on Chronic Kidney Disease
Sajidah Begum et al.
NUTRIENTS (2019)
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Zachary J. Hawula et al.
PHARMACEUTICALS (2019)
Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey
Andreas M. Hohlbaum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Ineffective Erythropoiesis: Anemia and Iron Overload
Ritama Gupta et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Changes in Hepcidin and Hemoglobin After Anti-TNF-alpha Therapy in Children and Adolescents With Crohn Disease
Meredith A. Atkinson et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Aspirin increases ferroportin 1 expression by inhibiting hepcidin via the JAK/STAT3 pathway in interleukin 6-treated PC-12 cells
Su-Na Huang et al.
NEUROSCIENCE LETTERS (2018)
An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in -thalassemia major patients: A double-blind randomized controlled clinical trial
Elahe Mohammadi et al.
PHYTOTHERAPY RESEARCH (2018)
Physiological effects of modulating the interleukin-6 axis
Georg Schett
RHEUMATOLOGY (2018)
MyD88 Adaptor Protein Is Required for Appropriate Hepcidin Induction in Response to Dietary Iron Overload in Mice
Antonio Layoun et al.
FRONTIERS IN PHYSIOLOGY (2018)
Novel Liposome Eencapsulated Guanosine Di Phosphate based Therapeutic Target against Anemia of Inflammation
Stanzin Angmo et al.
SCIENTIFIC REPORTS (2018)
Inherited Disorders of Iron Overload
Kostas Pantopoulos
FRONTIERS IN NUTRITION (2018)
The effectiveness of etanercept and adalimumab on anemia of chronic disease and serum hepcidin in patients with rheumatoid arthritis, a comparative study
M. H. Abu-Zaid et al.
EGYPTIAN RHEUMATOLOGIST (2018)
Erythroferrone inhibits the induction of hepcidin by BMP6
Joao Arezes et al.
BLOOD (2018)
Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin
Sharraya Aschemeyer et al.
BLOOD (2018)
FP660PHARMACOKINETICS AND PHARMACODYNAMICS OF LEXAPTEPID, A NOVEL ANTI-HEPCIDIN MOLECULE, IN ESA-RESISTANT HAEMODIALYSIS PATIENTS
Iain C Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study
Fabrice Laine et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Overview of iron metabolism in health and disease
Som Dev et al.
HEMODIALYSIS INTERNATIONAL (2017)
Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway
Mastura Wahedi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
Saroj Vadhan-Raj et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
Sant-Rayn Pasricha et al.
NATURE COMMUNICATIONS (2017)
From the Cradle to the Grave: The Role of Macrophages in erythropoiesis and erythrophagocytosis
Thomas R. L. Klei et al.
FRONTIERS IN IMMUNOLOGY (2017)
Identification of Guanosine 5′-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway
Stanzin Angmo et al.
SCIENTIFIC REPORTS (2017)
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Cadiele Oliana Reichert et al.
ACTA HAEMATOLOGICA (2017)
The effects of iron fortification and supplementation on the gut microbiome and diarrhea in infants and children: a review
Daniela Paganini et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Excess iron intake as a factor in growth, infections, and development of infants and young children
Bo Lonnerdal
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Current understanding of iron homeostasis
Gregory J. Anderson et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
AMPK Serves as a Therapeutic Target Against Anemia of Inflammation
Minjun Wang et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff et al.
BLOOD (2017)
Regulation of the Iron Homeostatic Hormone Hepcidin
Veena Sangkhae et al.
ADVANCES IN NUTRITION (2017)
Eicosapentaenoic acid and docosahexaenoic acid in fish oil capsule supplementation in obese children decreases serum interleukin-6 and hepcidin and improves iron status
I. Gusti Lanang Sidiartha et al.
BALI MEDICAL JOURNAL (2017)
Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus Monkeys
Wojciech Krzyzanski et al.
AAPS JOURNAL (2016)
Regulation of Hepcidin by Erythropoiesis: The Story So Far
Sant-Rayn Pasricha et al.
ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)
Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
M. Boyce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
Suzana Kovac et al.
HAEMATOLOGICA (2016)
Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations
Ertan Sal et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2016)
Iron Fortification of Foods for Infants and Children in Low-Income Countries: Effects on the Gut Microbiome, Gut Inflammation, and Diarrhea
Daniela Paganini et al.
NUTRIENTS (2016)
Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
Suzana Kovac et al.
HAEMATOLOGICA (2016)
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure
Philip Barrington et al.
BLOOD (2016)
Hepcidin: regulation of the master iron regulator
Gautam Rishi et al.
BIOSCIENCE REPORTS (2015)
The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease
Ioannis E. Koutroubakis et al.
INFLAMMATORY BOWEL DISEASES (2015)
The iron-regulatory hormone hepcidin: A possible therapeutic target?
Luc Rochette et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Association of oral iron supplementation with birth outcomes in non-anaemic South Indian pregnant women
L. Shastri et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2015)
Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants
Tanja Jaeggi et al.
GUT (2015)
Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation
Daniel Horbelt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mechanisms of Jak/STAT Signaling in Immunity and Disease
Alejandro V. Villarino et al.
JOURNAL OF IMMUNOLOGY (2015)
A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjects
Ulrich Moebius et al.
BLOOD (2015)
Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus
Sara Gardenghi et al.
BLOOD (2014)
Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
Lucas T. van Eijk et al.
BLOOD (2014)
The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study
Pencho Georgiev et al.
CANCER RESEARCH (2014)
Resistance of Ferroportin to Hepcidin Binding causes Exocrine Pancreatic Failure and Fatal Iron Overload
Sandro Altamura et al.
CELL METABOLISM (2014)
A structural model of human ferroportin and of its iron binding site
Maria C. Bonaccorsi di Patti et al.
FEBS JOURNAL (2014)
Anticalins: Exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins
A. Richter et al.
FEBS LETTERS (2014)
Anemia of Inflammation
Elizabeta Nemeth et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Iron-Refractory Iron Deficiency Anemia (IRIDA)
Matthew M. Heeney et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical
Yoshiya Tanaka et al.
Modern Rheumatology (2014)
The Molecular Biology of Human Iron Metabolism
William E. Winter et al.
LABMEDICINE (2014)
Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway
Zhong-Ming Qian et al.
MOLECULAR NEUROBIOLOGY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
The pathophysiology and pharmacology of hepcidin
Piotr Ruchala et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Maura Poli et al.
FRONTIERS IN PHARMACOLOGY (2014)
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
Richard N. Wang et al.
GENES & DISEASES (2014)
Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor
Agustin H. Mohedas et al.
ACS CHEMICAL BIOLOGY (2013)
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
Annkristin Heine et al.
BLOOD (2013)
A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates
Keegan S. Cooke et al.
BLOOD (2013)
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
Frank Schwoebel et al.
BLOOD (2013)
The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study)
Eleni Papadopoulou et al.
EUROPEAN JOURNAL OF NUTRITION (2013)
Manipulation of the hepcidin pathway for therapeutic purposes
Eileen Fung et al.
HAEMATOLOGICA (2013)
Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells
Pamela Urrutia et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese et al.
JOURNAL OF RHEUMATOLOGY (2013)
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
A. Pardanani et al.
LEUKEMIA (2013)
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
Soken-Nakazawa J. Song et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Multi-Copper Oxidases and Human Iron Metabolism
Ganna Vashchenko et al.
NUTRIENTS (2013)
High-Throughput Screening of Small Molecules Identifies Hepcidin Antagonists
Eileen Fung et al.
MOLECULAR PHARMACOLOGY (2013)
Role of hepcidin in the pathophysiology and diagnosis of anemia
Guido D'Angelo
BLOOD RESEARCH (2013)
Iron Homeostasis in the Liver
Erik R. Anderson et al.
COMPREHENSIVE PHYSIOLOGY (2013)
LY2928057, A Antibody Targeting Ferroportin, Is a Potent Inhibitor Of Hepcidin Activity and Increases Iron Mobilization In Normal Cynomolgus Monkeys
Derrick R. Witcher et al.
BLOOD (2013)
Ferroportin-mediated iron transport: Expression and regulation
Diane M. Ward et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling
Celine Besson-Fournier et al.
BLOOD (2012)
Rice fortification: An emerging opportunity to contribute to the elimination of vitamin and mineral deficiency worldwide
Sumithra Muthayya et al.
FOOD AND NUTRITION BULLETIN (2012)
Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection
Peggy Schwarz et al.
GUT (2012)
JAK's SOCS: A Mechanism of Inhibition
Akihiko Yoshimura et al.
IMMUNITY (2012)
Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis
Paulo C. J. L. Santos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Polysaccharide Isolated from Angelica sinensis Inhibits Hepcidin Expression in Rats with Iron Deficiency Anemia
Jin-Yu Liu et al.
JOURNAL OF MEDICINAL FOOD (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumor Necrosis Factor α Inhibits Expression of the Iron Regulating Hormone Hepcidin in Murine Models of Innate Colitis
Nanda Kumar N. Shanmugam et al.
PLOS ONE (2012)
Micronized ferric pyrophosphate supplied through extruded rice kernels improves body iron stores in children: a double-blind, randomized, placebo-controlled midday meal feeding trial in Indian schoolchildren
Madhari S. Radhika et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Maura Poli et al.
BLOOD (2011)
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice
Andrea U. Steinbicker et al.
BLOOD (2011)
Understanding the Structure/Activity Relationships of the Iron Regulatory Peptide Hepcidin
Richard J. Clark et al.
CHEMISTRY & BIOLOGY (2011)
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Toshio Tanaka et al.
FEBS LETTERS (2011)
Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors
Sant-Rayn Pasricha et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Diagnosis and management of iron deficiency anemia in the 21st century
Terri D. Johnson-Wimbley et al.
Therapeutic Advances in Gastroenterology (2011)
Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys
Jim J. Xiao et al.
AAPS JOURNAL (2010)
Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep-/-) mouse
Robert C. Cooksey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Iron-Induced Expression of Bone Morphogenic Protein 6 in Intestinal Cells Is the Main Regulator of Hepatic Hepcidin Expression In Vivo
Stephanie Arndt et al.
GASTROENTEROLOGY (2010)
Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice
Ivana De Domenico et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Activation and inactivation of the iron hormone hepcidin: Biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin isoforms
Melanie Schranz et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes
Guillemette Ramey et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Janus Kinase 2 Inhibitor AG490 Inhibits the STAT3 Signaling Pathway by Suppressing Protein Translation of gp130
In Ae Seo et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2009)
Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2
Ivana De Domenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005
Erin McLean et al.
PUBLIC HEALTH NUTRITION (2009)
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα
Jorge P. Pinto et al.
BLOOD (2008)
Novel erythropoiesis-stimulating agents: A new era in anemia management
Iain C. Macdougall
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Body iron metabolism and pathophysiology of iron overload
Yutaka Kohgo et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Pancreatic β-cells express hepcidin, an iron-uptake regulatory peptide
Hasan Kulaksiz et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Mechanisms of heme iron absorption: Current questions and controversies
Adrian R. West et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Paul B. Yui et al.
NATURE CHEMICAL BIOLOGY (2008)
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis
Fatoumata B. Sow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4
Lan Lin et al.
BLOOD (2007)
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Jodie L. Babitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The molecular mechanism of hepcidin-mediated ferroportin down-regulation
Ivana De Domenico et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation
Uta Merle et al.
ENDOCRINOLOGY (2007)
Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis
Alexandra Rideau et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Maria Vittoria Verga Falzacappa et al.
BLOOD (2007)
Suppression of hepcidin during anemia requires erythropoietic activity
Mihwa Pak et al.
BLOOD (2006)
Extruded rice fortified with micronized ground ferric pyrophosphate reduces iron deficiency in Indian schoolchildren: a double-blind randomized controlled trial
Diego Moretti et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH
Soumeya Bekri et al.
GASTROENTEROLOGY (2006)
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
Jaroslav Truksa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of iron acquisition and iron distribution in mammals
Tomas Ganz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study
E Nemeth et al.
BLOOD (2006)
A role of SMAD4 in iron metabolism through the positive regulation of hepicidin expression
RH Wang et al.
CELL METABOLISM (2005)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Spiegelmers: Biostable aptamers
D Eulberg et al.
CHEMBIOCHEM (2003)
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
E Nemeth et al.
BLOOD (2003)
C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism
B Courselaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
CH Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An iron-regulated ferric reductase associated with the absorption of dietary iron
AT McKie et al.
SCIENCE (2001)
Intestinal iron absorption: current concepts circa 2000
NC Andrews
DIGESTIVE AND LIVER DISEASE (2000)
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
A Krause et al.
FEBS LETTERS (2000)
Share Paper
